Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Sonoma Pharmaceuticals, Inc.
| Metric | Sonoma Pharmaceuticals, Inc. SNOAHealthcare |
|---|---|
| Quality Score | 50 / 100 |
| Revenue (latest) | $14M |
| Net income (latest) | −$3M |
| Operating margin | −26.0% |
| Net margin | −24.2% |
| Return on equity | −78.4% |
| Return on assets | −25.2% |
| Return on capital (ROCE) | −38.7% |
| Debt / equity | 2.10× |
| Revenue growth (YoY) | 12.2% |
| Altman Z″ (distress) | -44.32 |
| Accruals / assets | −24.6% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.